|国家科技期刊平台
首页|期刊导航|中国实用儿科杂志|益生菌儿科临床应用循证指南(2023)

益生菌儿科临床应用循证指南(2023)OACSTPCD

Evidence-based guideline for pediatric clinical application of probiotics(2023)

中文摘要英文摘要

益生菌作为药物、食品或膳食补充剂用于儿科疾病防治的有效性和安全性已被广泛证实.近年来关于益生菌的研究数据不断更新.为了使医师更好地认识和使用益生菌,中华预防医学会微生态学分会儿科专家在2017年发布的《益生菌儿科临床应用循证指南》基础上,查询国内外新发表的文献并结合中国当前实际情况,制定指南,以期指导我国儿科临床规范应用益生菌.

The efficacy and safety of probiotics as drugs,foods or dietary supplements for the prevention and treatment of pediatric diseases have been widely confirmed.In recent years,research on probiotics has been continuously updated.To help physicians better understand and use probiotics,pediatric experts from the Microecology Branch of the Chinese Society of Preventive Medicine have developed this guideline based on the"Evidence-Based Guideline for Pediatric Clinical Application of Probiotics"published in 2017,combined newly published literature from China and abroad,and considered the current actual situation in China,with a view to guiding the standard clinical application of probiotics in pediatrics in China.

中华预防医学会微生态学分会;舒赛男;王文建

华中科技大学同济医学院附属同济医院深圳市儿童医院

临床医学

益生菌循证指南儿童

probioticsevidence-based guidelinechild

《中国实用儿科杂志》 2024 (001)

1-15,20 / 16

10.19538/j.ek2024010601

评论